These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8279756)
21. Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. McGuire Wl; Meyer JS; Barlogie B; Kute TE Breast Cancer Res Treat; 1985; 5(2):117-28. PubMed ID: 2410071 [No Abstract] [Full Text] [Related]
22. [Correlation of histologically determined receptor state and the clinical course in tumors of the breast]. Ghislandi E; Gottardi O Pathologica; 1985; 77(1049):323-35. PubMed ID: 3831883 [No Abstract] [Full Text] [Related]
23. Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer. Benner SE; Clark GM; McGuire WL Am J Med Sci; 1988 Jul; 296(1):59-66. PubMed ID: 3044107 [TBL] [Abstract][Full Text] [Related]
24. [Prognostic factors in breast cancer with contralateral supraclavicular or axillary lymphatic metastases]. Muñoz-González D; Mora-Tizcareño A; Ramírez-Ugalde MT; Pérez-Sánchez M; Sánchez-Valdivieso E; Gómez-Ruiz C; Zeichner-Gancz I Rev Invest Clin; 1998; 50(1):25-30. PubMed ID: 9608786 [TBL] [Abstract][Full Text] [Related]
25. More treatment options for women with hormone receptor-positive breast cancer: guideline update, studies lead to advances in care. Printz C Cancer; 2014 Oct; 120(19):2939-40. PubMed ID: 25241884 [No Abstract] [Full Text] [Related]
26. [Cancer of the breast and the receptor status]. Buonomo O; Serao A; Muggianu A; Guglielmelli E; Davoli E; Amori A G Chir; 1991 Apr; 12(4):274-7. PubMed ID: 1911078 [TBL] [Abstract][Full Text] [Related]
27. [Prognostic value of thymidine kinase in cancer of the breast]. Romain S; Javre JL; Samperez S; Jouan P; Bressac C; Varette I; Brandone H; Martin PM Bull Cancer; 1990; 77(10):973-83. PubMed ID: 2249017 [TBL] [Abstract][Full Text] [Related]
28. [Value of neo-angiogenesis evaluation in cancer of the breast]. Namer M; Ettore R; Pivot X; Ferrero JM; Teissier E Bull Cancer; 1996 Dec; 83(12):1041-2. PubMed ID: 9116372 [No Abstract] [Full Text] [Related]
29. Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancer. Paradiso A; Ventrella V; Farchi G; Tommasi S; Mangia A; Barletta A; Schittulli F; Racanelli A; De Lena M Oncology; 1993; 50(2):104-9. PubMed ID: 8383827 [TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy with accelerated CNF plus G-CSF in patients with breast cancer tumors larger than three centimeters: a pilot study. Lorusso V; Catino A; Schittulli F; Longo S; Racanelli A; Timurian A; Marzullo F; Simone G; Brandi M; De Lena M Int J Oncol; 1998 May; 12(5):1177-81. PubMed ID: 9538146 [TBL] [Abstract][Full Text] [Related]
31. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics. Hähnel R; Harvey J; Robbins P; Sterrett G Anticancer Res; 1993; 13(6A):2131-5. PubMed ID: 8297125 [TBL] [Abstract][Full Text] [Related]
32. [Clinical and morphological features and treatment for lobular breast cancer]. Tabagua TT; Semiglazov VV; Bus'ko EA; Semiglazova TIu; Voroshnikov VV Vopr Onkol; 2013; 59(3):386-9. PubMed ID: 23909043 [TBL] [Abstract][Full Text] [Related]
33. Prognostic relevance of serum hyaluronan levels in patients with breast cancer. Ponting J; Howell A; Pye D; Kumar S Int J Cancer; 1992 Dec; 52(6):873-6. PubMed ID: 1459727 [TBL] [Abstract][Full Text] [Related]
34. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark. Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT; J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042 [TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for breast cancer and their use in the clinical setting. Kapoor A; Vogel VG Expert Rev Anticancer Ther; 2005 Apr; 5(2):269-81. PubMed ID: 15877524 [TBL] [Abstract][Full Text] [Related]
36. p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer. Clahsen PC; van de Velde CJ; Duval C; Pallud C; Mandard AM; Delobelle-Deroide A; van den Broek L; Sahmoud TM; van de Vijver MJ J Clin Oncol; 1998 Feb; 16(2):470-9. PubMed ID: 9469330 [TBL] [Abstract][Full Text] [Related]
38. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment. Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452 [TBL] [Abstract][Full Text] [Related]
39. [Does obesity modify recurrence-free interval in breast cancer?]. Kurz C; Obermair A; Schemper W; Kubista E; Sevelda P Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():305-7. PubMed ID: 8118326 [No Abstract] [Full Text] [Related]
40. Predicting recurrence and survival in breast cancer. A panel discussion. McGuire WL; Clark GM; Fisher ER; Henderson IC Breast Cancer Res Treat; 1987; 9(1):27-38. PubMed ID: 3593989 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]